United States ex rel. Mastej v. Health Management Associates, Inc.

869 F. Supp. 2d 1336, 2012 WL 523623, 2012 U.S. Dist. LEXIS 19301
CourtDistrict Court, M.D. Florida
DecidedFebruary 16, 2012
DocketCase No. 2:11-cv-89-FtM-29DNF
StatusPublished
Cited by20 cases

This text of 869 F. Supp. 2d 1336 (United States ex rel. Mastej v. Health Management Associates, Inc.) is published on Counsel Stack Legal Research, covering District Court, M.D. Florida primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States ex rel. Mastej v. Health Management Associates, Inc., 869 F. Supp. 2d 1336, 2012 WL 523623, 2012 U.S. Dist. LEXIS 19301 (M.D. Fla. 2012).

Opinion

OPINION AND ORDER

JOHN E. STEELE, District Judge.

This matter comes before the Court on Defendants’ Joint Motion to Dismiss the Second Amended Complaint (Doc. # 59) filed on May 17, 2011, by defendants Health Management Associates, Inc. (MHA) and Naples HMA, LLC (Naples HMA) (collectively, the defendants). Plaintiff, Relator J. Michael Mastej (relator or Mastej) filed a memorandum in opposition to the motion on May 31, 2011. (Doc. # 60.) Defendants filed a reply in support of their motion. (Doc. # 64.) The United States (the Government), although it declined to intervene (Doc. # 76), filed a statement of interest in response to the motion (Doc. # 65) to which defendants filed a response. (Doc. # 66.)

I.

Mastej brought this qui tam1 action asserting violations of the False Claims Act, 31 U.S.C. § 3729 et seq. (FCA) through violations of the Stark Law2 and the Anti-Kickback Statute.3 He asserts four causes of action under the False Claims Act: (1) presentation of false claims4 (Count I); (2) making or using a false record or statement to cause a claim to be paid5 (Count II); (3) making or using a false record or statement to avoid an obligation or refund6 (Count III); and (4) conspiring to [1340]*1340commit false claims7 (Count IV).

The defendants assert that the Second Amended Complaint should be dismissed because relator failed to meet the pleadings requirements set forth in the Federal Rules of Civil Procedure. In response, Mastej contends that he has met the pleading requirements and alternatively asserts that he should be granted leave to amend his complaint.8 For the reasons discussed below, the Court finds that relator has failed to meet the pleading requirements set forth in Rule 9 but will grant him leave to amend.

II.

In deciding a motion to dismiss, the Court must accept all factual allegations in a complaint as true and take them in the light most favorable to plaintiff. Erickson v. Pardus, 551 U.S. 89, 127 S.Ct. 2197, 167 L.Ed.2d 1081 (2007); Christopher v. Harbury, 536 U.S. 403, 406, 122 S.Ct. 2179, 153 L.Ed.2d 413 (2002). “To survive dismissal, the complaint’s allegations must plausibly suggest that the [plaintiff] has a right to relief, raising that possibility above a speculative level; if they do not, the plaintiffs complaint should be dismissed.” James River Ins. Co. v. Ground Down Eng’g, Inc., 540 F.3d 1270, 1274 (11th Cir.2008) (citing Bell Atl. Corp. v. Twombly, 550 U.S. 544, 555-56, 127 S.Ct. 1955, 167 L.Ed.2d 929 (2007)).

The Eleventh Circuit requires that in order to avoid dismissal of a FCA claim, a relator must plead “facts as to time, place, and substance of the defendants’ alleged fraud, specifically, the details of the defendants’ allegedly fraudulent acts, when they occurred, and who engaged in them.” United States ex rel. Seal v. Lockheed Martin Corp., 429 Fed.Appx. 818, 820 (11th Cir.2011); citing United States ex rel. Sanchez v. Lymphatx, Inc., 596 F.3d 1300, 1302 (11th Cir.2010); see also United States ex rel. Clausen v. Lab. Corp. of Am., 290 F.3d 1301, 1310 (11th Cir.2002); United States ex rel. Shurick v. Boeing Company, 330 Fed.Appx. 781, 783 (11th Cir.2009) (“the complaint must allege facts as to time, place and substance of the defendants’s alleged fraud, [and] the details of the defendants allegedly fraudulent acts, when they occurred, and who engaged in them.”) Failure to satisfy Rule 9(b) is grounds to dismiss the Complaint. Corsello v. Lincare, Inc., 428 F.3d 1008, 1012 (11th Cir.2005).

Rule 9(b)’s particularity requirement for fraud allegations exists to put defendants on notice as to the exact misconduct with which they are charged and to protect defendants against spurious charges. Ziemba v. Cascade Int’l, Inc., 256 F.3d 1194, 1202 (11th Cir.2001). The Eleventh Circuit has cautioned that “Rule 9(b) must not be read to abrogate rule 8, however, and a court considering a motion to dismiss for failure to plead fraud with particularity should always be careful to harmonize the directives of rule 9(b) with the broader policy of notice pleading.” Friedlander v. Nims, 755 F.2d 810, 813 n. 3 (11th Cir.1985).

III.

The Second Amended Complaint alleges the following:

Defendant HMA is a public company incorporated in Delaware. It has various subsidiaries and operates approximately fifty-six (56) hospitals in fifteen (15) states. [1341]*1341Defendant HMA Naples is a HMA subsidiary doing business as “Physicians Regional Medical Center.” Physicians Regional Medical Center has two campuses that operate under the same license and provider number: (1) Physicians Regional Medical Center, Collier Boulevard (Collier Boulevard Facility) and (2) Physicians Regional Medical Center, Pine Ridge (Pine Ridge Facility). (Doc. # 58, ¶¶ 54, 57.)

Relator was employed in various capacities by defendant HMA, or one of its subsidiaries, from January 2001 through October 2007. On February 5, 2007, he became Chief Executive Officer (CEO) of the Collier Boulevard Facility. Relator contends that both during and after his employment the defendants participated in three (3) separate schemes to present false claims to the federal government in violation of the FCA.

A. Scheme One

In the first of these schemes, relator alleges that despite the fact that neither the Collier Boulevard nor Pine Ridge Facilities offered emergency surgery or emergency neurosurgery services, Geoff Moebius (Moebius), the CEO of the Pine Ridge facility, negotiated call coverage contracts with the following neurosurgeons: Dr. Michael Lusk, Dr. John Dry-gas, Dr. Mark Gerber, and Dr. Rick Bhasin of Neuroscience and Spine Associates.9 Pursuant to the call coverage contracts, each neurosurgeon was paid $1,000 for each weekday and $2,000 for each weekend call coverage was provided. Relator contends that the total payments to these neurosurgeons were significantly above the fair market value for the services provided and were not commercially reasonable. Relator contends that Moebius informed him that the call contracts were important to keep the neurosurgeons referring lucrative scheduled surgeries at the Pine Ridge Facility.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
869 F. Supp. 2d 1336, 2012 WL 523623, 2012 U.S. Dist. LEXIS 19301, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-ex-rel-mastej-v-health-management-associates-inc-flmd-2012.